OZURDEX .7 mg/1
dexamethasone · IMPLANT · Allergan, Inc.
No Recall HistoryCurrently in Shortage
Plain English
OZURDEX is a implant containing dexamethasone at .7 mg/1, taken intravitreal. Manufactured by Allergan, Inc..
Key Facts
- Brand Name
- OZURDEX
- Generic Name
- dexamethasone
- NDC Code (Product)
0023-3348- Manufacturer
- Allergan, Inc.
- Strength
- .7 mg/1
- Dosage Form
- IMPLANT
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- NDA022315
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 09/01/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is OZURDEX used for?
OZURDEX contains dexamethasone. It is a implant taken intravitreal. Consult your doctor for specific uses.
Is OZURDEX a controlled substance?
OZURDEX is not classified as a controlled substance by the DEA.
What is the generic name for OZURDEX?
The generic name for OZURDEX is dexamethasone. There are 12 other brand versions of dexamethasone.
What is the NDC code for OZURDEX .7 mg/1?
The NDC (National Drug Code) for OZURDEX .7 mg/1 is 0023-3348, listed by Allergan, Inc..
Other Dexamethasone Brands
See all →- Dexamethasone6 mg/10054-8183
- Dexamethasone Sodium Phosphate10 mg/mL72485-118
- DEXAMETHASONE4 mg/172789-534
- DEXAMETHASONE2 mg/172888-239
- Dexamethasone Sodium Phosphate4 mg/mL76420-398
- Dexamethasone Sodium Phosphate10 mg/mL76420-399
- Mardex 25 Kit76420-810
- Dexamethasone4 mg/180425-0328
- Hemady20 mg/182111-955
- Dexamethasone1.5 mg/182804-132
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)